Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma

Circulation

Volumn 104, Issue 3, 2001, Pages 281-285

  Tanaka, Hiroshi ^a   Teramoto, Shin ^a   Oashi, Kensuke ^a   Saikai, Toyohiro ^a   Tanaka, Shintaro ^a   Suzuki, Kazuhiko ^a   Hashimoto, Midori ^a   Abe, Shosaku ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Asthma; Genes; Hypertension; Receptors

Indexed keywords

CALCIUM ANTAGONIST; CANDESARTAN; KININ; MANIDIPINE; METHACHOLINE; NIFEDIPINE;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG SAFETY; HUMAN; HYPERTENSION; INCIDENCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0035902452     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.104.3.281     Document Type: Article

References (27)

1. Cough with angiotensin converting enzyme inhibitors: How much of a problem?
2. Pharmaco-epidemiology of ACE inhibitor-induced cough
3. Angiotensin-I-converting enzyme gene polymorphism and susceptibility to cough
4. Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitors
5. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough
6. Use losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors
7. Human ACE gene polymorphism and distilled water induced cough
8. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor
9. Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in normal population
10. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
11. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
12. Cough associated with captopril and enalapril
13. Open clinical studies on a new angiotensin II receptor antagonist, TCV116
14. Quality of life on antihypertensive therapy: A randomized double-blind controlled trial of captopril and atenolol
15. Direct-writing recorder of the dose-response curves of the airway to methacholine
16. Comparison of intermittent and continuous inhalation provocation tests
17. Leukotriene (LT)-receptor antagonist is more effective on asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)Flα
18. Effect of angiotensin II receptor blockage on bronchial responsiveness in asthmatic subjects
19. Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function
20. Conversion of angiotensin I to angiotensin II by chymase activity in human pulmonary membranes
21. Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo
22. Effect of losartan, a type 1 angiotensin II receptor antagonist, on bronchial hyperresponsiveness to methacholine in patients with bronchial asthma
23. Respiratory effects of angiotensin converting enzyme inhibition
24. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: A double-blind, randomized, cross-over study
25. ACE inhibitors, cough and genetics
26. Genetic polymorphism of the angiotensin-converting enzyme (ACE) in asthmatic patients